Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HPE vs MRNA✓SelectedUSD · MRNAHPE vs MRNA performance historyLatest closeAs of-0.63%11/19
Stock and ETF performance explorer

HPE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+252.7%
MRNA return
-25.6%
Excess return
+278.4%
Maximum drawdown
-48.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.6%+1.3%-1.9%-0.7%
7D-9.3%-13.8%+4.5%-8.7%
30D-18.9%-17.7%-1.2%-18.3%
3M-14.2%+14.3%-28.5%-15.0%
6M+40.2%+336.0%-295.8%+21.9%
YTD+91.6%+575.9%-484.3%+54.6%
1Y+124.8%+724.4%-599.6%+75.7%
3Y+207.2%+160.8%+46.4%+168.3%
All+252.7%-25.6%+278.4%+220.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling